Association of estrogen receptor 1 intron 1 C/T polymorphism in Korean vitiligo patients

Journal of Dermatological Science

Volumn 35, Issue 3, 2004, Pages 181-186

  Jin, Sheng Yu ^a   Park, Hyun Ho ^a   Li, Guang Zhe ^a   Lee, Hee Jae ^a   Hong, Mee Suk ^a   Park, Hae Jeong ^a   Park, Hun Kuk ^a   Seo, Jung Chul ^b   Yim, Sung Vin ^a   Chung, Joo Ho ^a   Lee, Mu Hyoung ^a  

^a Kyung Hee University Hospital   (South Korea)

^b Daegu Haany University   (South Korea)

Author keywords

Estrogen receptor 1; Polymorphism; Vitiligo

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ENZYME SYNTHESIS; ESTROGEN RECEPTOR 1 GENE; EXON; FEMALE; GENE; GENE FREQUENCY; GENE IDENTIFICATION; GENE LOCATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INTERMETHOD COMPARISON; INTRON; KOREA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION MAPPING; STATISTICAL SIGNIFICANCE; VITILIGO;

ADOLESCENT; ADULT; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE FREQUENCY; HUMANS; INTRONS; KOREA; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; VITILIGO;

EID: 4644355534     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2004.06.008     Document Type: Article

References (38)

1. O.K. Stephen Vitiligo J. Am. Acad. Dermatol. 38 1998 647 666
2. I.C. Le Poole, P.K. Das, R.M. van den Wijngaard, J.D. Bos, and W. Westerhof Review of the etiopathomechanism of vitiligo: a convergence theory Exp. Dermatol. 2 1993 145 153
3. G. Finnish An autoimmune disease, APECED, caused by mutaions in a novel gene featuring two PHD-type zinc-finger domains Nat. Genet. 17 1997 399 403
4. E.H. Kemp, R.A. Ajjan, E.A. Waterman, D.J. Gawkrodger, M.J. Cork, and P.F. Watson Analysis of a microsatellite polymorphism of the cytotoxic T-lymphocyte antigen-4 gene in patients with vitiligo Br. J. Dermatol. 140 1999 73 78
5. D. Bandyopadhyay, E. Lawrence, P.P. Majumder, and R.E. Ferrell Vitiligo is not caused by mutations in GTP-cyclohydrolase 1 gene Clin. Exp. Dermatol. 25 2000 152 153
6. I.C. Le Poole, R. Sarangarajan, Y. Zhao, L.S. Stennett, T.L. Brown, and P. Sheth "VIT1", a novel gene associated with vitiligo Pigment Cell Res. 14 2001 475 484
7. M. Arcos-Burgos, E. Parodi, M. Salgar, E. Bedoya, J. Builes, and D. Jaramillo Vitiligo: complex segregation and linkage disequilibrium analyses with respect to microsatellite loci spanning the HLA Hum. Genet. 110 2002 334 342
8. C.B. Casp, J.X. She, and W.T. McCormack Genetic association of the catalase gene (CAT) with vitiligo susceptibility Pigment Cell Res. 15 2002 62 66
9. M.E. Erdal, U. Tursen, T.I. Kaya, A. Kanik, E. Derici, and G. Ikizoglu Association between catechol-O-methyltransferase polymorphism and vitiligo Arch. Dermatol. Res. 294 2002 143 146
10. S.Y. Jin, H.H. Park, G.Z. Li, H.J. Lee, M.S. Hong, and S.J. Hong Association of angiotensin converting enzyme gene I/D polymorphism of vitiligo in Korean population Pigment Cell Res. 17 2004 84 86
11. S.K. Nath, J.A. Kelly, B. Namjou, T. Lam, G.R. Bruner, and R.H. Scofield Evidence for a susceptibility gene, SLEV1, on chromosome 17q13 in families with vitiligo-related systemic lupus erythematosus Am. J. Hum. Genet. 69 2001 1401 1406
12. A. Alkhateeb, G.L. Stetler, W. Old, J. Talbert, C. Uhlhorn, and M. Taylor Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p31.3-p32.2 Hum. Mol. Genet. 11 2002 661 667
13. C.B. Casp, J.X. She, and W.T. McCormack Genes of the LMP/TAP cluster are associated with the human autoimmune disease vitiligo Genes Immun. 4 2003 492 499
14. P. Shahrad, and R. Marks A pharmacological effect of oestrogene on human epidermis Br. J. Dermatol. 97 1977 383 386
15. K. Nagai, M. Ichimiya, K. Yokoyama, Y. Hamamoto, and M. Muto Successful treatment of non-segmental vitiligo: systemic therapy with sex hormone-thyroid powder mixture Horm. Res. 54 2000 316 317
16. M. Ichimiya Immunohistochemical study of ACTH and alpha-MSH in vitiligo patients successfully treated with a sex steroid-thyroid hormone mixture J. Dermatol. 26 1999 502 506
17. M. Muto, H. Furumoto, A. Ohmura, and C. Asagami Successful treatment of vitiligo with a sex steroid-thyroid hormone mixture J. Dermatol. 22 1995 770 772
18. D. Metzger, J.H. White, and P. Chambon The human oestrogen receptor functions in yeast Nature 334 1988 31 36
19. R.M. Evans The steroid and thyroid hormone receptor superfamily Science 240 1988 889 895
20. G. Leclercq Molecular forms of the estrogen receptor in breast cancer J. Steroid. Biochem. Mol. Biol. 80 2002 259 272
21. M. Ponglikitmongkol, S. Green, and P. Chambon Genomic organization of the human oestrogen receptor gene EMBO J. 7 1988 3385 3388
22. L.P. Menasce, G.R. White, C.J. Harrison, and J.M. Boyle Localization of the estrogen receptor (ESR) locus to chromosome 6q25.1 by FISH and a simple post-FISH banding technique Genomics 17 1993 263 265
23. S. Green, P. Walter, V. Kumar, A. Krust, J.M. Bornert, and P. Argos Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A Nature 320 1986 134 139
24. S.J. Tsai, Y.C. Wang, C.J. Hong, and H.J. Chiu Association study of oestrogen receptor alpha gene polymorphism and suicidal behaviors in major depressive disorder Psychiatr. Genet. 13 2003 19 22
25. J.E. Curran, R.A. Lea, S. Rutherford, S.R. Weinstein, and L.R. Griffiths Association of estrogen receptor and glucocorticoid receptor gene polymorphisms with sporadic breast cancer Int. J. Cancer. 95 2001 271 275
26. Terwilliger JD, Ott J. Linkage disequilibrium between alleles at marker loci. In: Handbook of human genetic linkage, 1st. ed. Baltimore: Johns Hopkins University; 1994. p. 188-98.
27. S. Wright The interpretation of population structure by F-statistics with special regard to systenis of mating Evolution 19 1965 399 420
28. C.C. Cockerham, and B.S. Weir Covariances of relatives stemming from a population undergoing mixed self and random mating Biometrics 1 1984 157 164
29. D.P. Chakraborty, S. Roy, and A.K. Chakraborty Vitiligo, psoralen, and melanogenesis: some observations and understanding Pigment Cell Res. 9 1996 107 116
30. Y.K. Park, N.S. Kim, S.K. Hann, and S. Im Identification of autoantibody to melanocytes and characterization of vitiligo antigen in vitiligo patients J. Dermatol. Sci. 11 1996 111 120
31. F. Ohtake, K. Takeyama, T. Matsumoto, H. Kitagawa, Y. Yamamoto, and K. Nohara Modulation of oestrogen receptor signaling by association with the activated dioxin receptor Nature 423 2003 545 550
32. D.L. Ellis, R.G. Wheeland, and H. Solomon Estrogen and progesterone receptors in melanocytic lesions Arch. Dermatol. 121 1985 1282 1285
33. Im S, Lee ES, Kim W, On W, Kim J, Lee M, et al. Donor specific response of estrogen and progesterone on cultured human melanocytes. J Korean Med Sci 2002;17:58-64.
34. K. Suzuki, H. Nakazato, H. Matsui, H. Koike, H. Okugi, and B. Kashiwagi Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O- methyltransferase are associated with familial prostate carcinoma risk in a Japanese population Cancer 98 2003 1411 1416
35. P. Zuppan, J.M. Hall, M.K. Lee, M. Ponglikitmongkol, and M.C. King Possible linkage of the estrogen receptor gene to breast cancer in a family with late-onset disease Am. J. Hum. Genet. 48 1991 1065 1068
36. W.L. McGuire, G.C. Chamness, and S.A. Fuqua Estrogen receptor variants in clinical breast cancer Mol. Endocrinol. 5 1991 1571 1577
37. E. Ruza, E. Sotillo, L. Sierrasesumaga, C. Azcona, and A. Patino-Garcia Analysis of polymorphisms of the vitamin D receptor, estrogen receptor, and collagen Iα1 genes and their relationship with height in children with bone cancer J. Pediatr. Hematol. Oncol. 25 2003 780 786
38. Q. Cai, X.O. Shu, F. Jin, Q. Dai, W. Wen, and J.R. Cheng Genetic polymorphisms in the estrogen receptor α gene and risk of breast cancer: results from the Shanghai Breast cancer study Cancer Epidemiol. Biomarkers Prev. 12 2003 853 859